NASDAQ:QNRX
Quoin Pharmaceuticals, Ltd. Stock Company Profile
$0.790
+0.0368 (+4.89%)
At Close: May 08, 2024
Information
42127 Pleasant Forest Court
Ashburn VA 20148-7349
703 980 4182
quoinpharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
